Table 1.
Pre-BCID2 Cohort (n = 99) |
BCID2 Cohort (n = 86) |
p-Value | |
---|---|---|---|
Study population per centre, N (%) | <0.0001 | ||
Rashid Hospital | 77 (77.8%) | 37 (43.0%) | |
Sheikh Khalifa General Hospital | 13 (13.1%) | 43 (50.0%) | |
Mediclinic City Hospital | 9 (9.1%) | 6 (7.0%) | |
Age in years, median (IQR) | 56 (40–65) | 65 (45–79) | 0.001 |
Age class, N (%) | 0.002 | ||
18–30 years old | 8 (8.1%) | 7 (8.1%) | |
31–40 years old | 17 (17.2%) | 4 (4.7%) | |
41–50 years old | 13 (13.1%) | 14 (16.3%) | |
51–60 years old | 26 (26.3%) | 13 (15.1%) | |
61–70 years old | 19 (19.2%) | 14 (16.3%) | |
71–85 years old | 16 (16.2%) | 34 (39.5%) | |
Sex, N (%) | 0.433 | ||
Male | 70 (70.7%) | 56 (65.1%) | |
Female | 29 (29.3%) | 30 (34.9%) | |
Vital signs on ICU admission, median (IQR) | |||
Oxygen saturation (%) | 98 (95.0–100.0) 1 | 97 (96.0–99.0) 2 | 0.194 |
Pulse rate (bpm) | 93 (86.0–111.0) 3 | 101 (89.0–114.0) | 0.177 |
Systolic blood pressure (mmHg) | 107.5 (90.0–126.5) 3 | 108 (95.0–122.0) | 0.695 |
Diastolic blood pressure (mmHg) | 64 (52.0–74.25) 3 | 58.5 (49.0–68.0) | 0.073 |
Comorbidities, N (%) | |||
Hypertension | 46 (46.5%) | 44 (51.2%) | 0.557 |
Diabetes | 45 (45.5%) | 35 (40.7%) | 0.554 |
Cardiac disease | 29 (29.3%) | 29 (33.7%) | 0.530 |
Chronic lung disease | 9 (9.1%) | 28 (32.6%) | 0.0001 |
Malignancy | 15 (15.2%) | 8 (9.3%) | 0.269 |
Immunosuppressive treatment | 6 (6.1%) | 4 (4.7%) | 0.753 |
SOT | 3 (3.0%) | 2 (2.3%) | 1.000 |
HSCT | 2 (2.0%) | 0 (0.0%) | 0.500 |
Number of comorbidities, N (%) | 0.221 | ||
0 | 33 (33.3%) | 20 (23.3%) | |
1 | 17 (17.2%) | 14 (16.3%) | |
2 | 21 (21.2%) | 29 (33.7%) | |
3 | 20 (20.2%) | 15 (17.4%) | |
4 to 5 | 8 (8.1%) | 8 (9.3%) |
1 N = 97 (two missing results). 2 N = 84 (two missing results). 3 N = 98 (one missing result). Abbreviations: bpm, beats per minute; HSCT, haematopoietic stem cell transplantation; IQR, interquartile range; mmHg, millimeters of mercury; SOT, solid-organ transplantation.